New CFO
prior company
micrografx.com
biz.yahoo.com
Healthaxis Inc. Names John M. Carradine Chief Financial Officer
EAST NORRITON, Pa.--(BUSINESS WIRE)--Mar. 8, 2001--Healthaxis, a leading provider of Web-enabling software solutions for healthcare payers and intermediaries, today announced that John M. Carradine has been named Chief Financial Officer for Healthaxis Inc. (NASDAQ:HAXS - news) and its wholly-owned operating subsidiary, Healthaxis.com, Inc., effective March 19, 2001.
In this role, Carradine will focus on strategic planning, investor relations, treasury functions, financial management and modeling, and will be responsible for all aspects of the company's financial and accounting operations.
``John Carradine is an exciting addition to the Healthaxis team,'' said James W. McLane, Healthaxis' President and Chief Executive Officer. ``John brings a successful track record of financial management and strategic planning in private and public software development companies. His experience and proven leadership abilities will be instrumental in ensuring that Healthaxis achieves its growth targets and delivers on its promises to its customers, its employees and its shareholders.''
``This is an outstanding opportunity,'' stated Carradine. ``Healthaxis has all of the components needed to become a leader in the healthcare technology solutions marketplace. I look forward to the challenges ahead and to working with the management team and proven technology professionals at Healthaxis to help the company grow successfully.''
Mr. Carradine comes to Healthaxis with over 20 years of experience in accounting, treasury and financial management.
Most recently, Carradine served as Chief Financial Officer and a director of Micrografx, Inc., a publicly traded, $40 million software development and services company with operations in the United States, Europe, Japan, and Australia, where he was responsible for worldwide financial and administrative functions including all finance and accounting, technology operations, planning, and investor relations.
Prior to Micrografx, Carradine served as Vice President of Finance and Chief Financial Officer of Intellicall, Inc., an American Stock Exchange listed manufacturer and provider of telecommunications products and services both in the United States and overseas.
Carradine began his career with Arthur Young and Company as an Auditor and subsequently served as Treasurer for Computer Language Research, Inc., a provider of software and data processing services.
About Healthaxis
Healthaxis develops and implements state-of-the-art software solutions for healthcare benefits administration and distribution. These solutions reduce costs, improve productivity, promote efficiency, and enhance customer service.
Healthaxis develops innovative solutions that offer businesses in the healthcare industry strategic advantages by quickly and efficiently connecting payers, providers, administrators, brokers, employers, and consumers (members/patients/employees).
Healthaxis technology solutions enable customers to remain compliant with evolving federal regulations such as HIPAA. Healthaxis products and services support customers by easily integrating flexible Internet-based applications - matching the customer's way of doing business with the demands of the Internet marketplace.
Healthaxis Inc. (NASDAQ:HAXS - news) - For investor information, call 610/275-3800. For information on Healthaxis products and software solutions call 800/519-0679 or visit www.healthaxis.com. Healthaxis, e-powering healthcare.
Note on forward-looking statements: All statements, trend analyses and other information contained in this release and elsewhere (such as in filings by Healthaxis Inc. with the Securities and Exchange Commission, press releases, presentations by Healthaxis Inc. or its management or oral statements) relative to markets for Healthaxis' products and trends in Healthaxis' operations or financial results, as well as other statements including words such as ``anticipate,'' ``believe,'' ``plan,'' ``estimate,'' ``expect,'' ``intend,'' ``should,'' ``could,'' ``goal,'' ``target,'' ``on track,'' ``comfortable with,'' ``optimistic'' and other similar expressions, constitute forward-looking statements under the Private Securities Litigation Reform Act of 1995.
These forward-looking statements are subject to known and unknown risks, uncertainties and other factors, which may cause actual results to be materially different from those contemplated by the forward-looking statements.
Such factors include, among other things: (1) general economic and business conditions, including changes in purchasing patterns, prevailing interest rate levels, stock and credit market performance and health care inflation, which may affect (among other things) Healthaxis' ability to sell its products and have access to capital resources; (2) Healthaxis' ability to achieve anticipated levels of operational efficiencies; (3) customer response to new products, distribution channels and marketing initiatives; (4) changes in the Federal income tax laws and regulations; (5) increasing competition in the sale of software solutions for the healthcare industry; (6) regulatory changes or actions, including health care regulation affecting the health insurance industry and software solutions products related to this industry; (7) actions by rating agencies and the effects of past or future actions by these agencies on Healthaxis' business; and (8) the risk factors or uncertainties listed from time to time in Healthaxis' filings with the Securities and Exchange Commission.
--------------------------------------------------------------------------------
Contact:
Healthaxis Inc.
Steven M. Kaplan, 610/275-3800
skaplan@healthaxis.com |
